S. no | Age | Sex | Cause/setting | Duration (days) | Clinical findings | Initial BCVA | Primary intervention | IOAB (repeat) | Prognosis | Reason | Final BCVA |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 32 | F | ECCE+ PCIOL | 300 | AC reaction, endoexudates, vitritis grade 2 | CF3M | PPV + IOAB (V + C) | NIL | Favourable | – | 20/200 |
2 | 32 | M | BB+ PPV+ EL+SOI | 13 | AC reaction, endoexudates, vitritis grade 4 | PL+ | SOR + IOAB (V + C + amp B) | V + C | Unfavourabe | Phthisis | PL- |
3 | 69 | F | PHACO + IOL | 90 | Hypopyon, pas, exudative membrane on IOL, vitritis grade 4 | PL+ | PPV + IOAB (V + amp B) | V + A + Dx | Unfavourable | Evisceration | PL- |
4 | 50 | M | SICS+ PCIOL | 29 | Hypopyon, vitritis grade 3 | CF 1m | PPV + VIT BX + IOAB (V + Vo) | V + A + Dx | Unfavourable | Recurrent vitritis, optic atrophy | PL+ |
5 | 64 | F | DSEK | 45 | PAS+, AC reaction, vitritis 3+ | PL+ | PPV + IOL Explant + IOAB (V + Dx) | V + Dx | Unfavourable | Recurrent vitritis, optic atrophy | PL+ |